What's new at Xpedite Diagnostics?

Xpedite Diagnostics GmbH, a leader in improving molecular testing accessibility for the life sciences, proudly announces the launch of a groundbreaking products, SwiftX cfDNA. This advanced solution enhances the company's robust portfolio, building upon its established expertise…

We're proud to announce that together with Leiden University Medical Center, we've won the Best Poster Award at the recent Conference on Tropical Medicine, held in Dusseldorf, Germany.

The work focuses on a simple and rapid approach for Schistosoma CAA antigen enrichment using…

We’re excited to share that Xpedite Diagnostics is now ISO 13485 certified! Our products are CE IVD-R registered and this certification marks a significant achievement, reflecting our commitment to adhering to the highest international standards in medical device quality…

Xpedite Diagnostics funded for contribution in veterinary diagnostics project.

A consortium including Xpedite Diagnostics has been selected for funding within the EU HORIZON program.

EUROIMMUN and Xpedite Diagnostics join forces for offering faster and easier protocols for DNA extraction at the point-of-care.

Good news for all who are looking for a rapid yet sensitive DNA extraction solution for infectious disease testing. Here it is: SwiftX™ ParaBact!

Last week we hosted a customer who is aiming to utilize our mobile molecular laboratory for environmental testing.

Xpedite Diagnostics has moved to it's new headquarter in the Munich Airport Business Park in Hallbergmoos, which is just 10 minutes away from the airport.

Xpedite Diagnostics signed agreement for development of a tailored nucleic acid extraction solution.